Pharmaceutical & Medical Device Update, Vol. IV, Issue III
Read the full Pharmaceutical & Medical Device Update, Vol. IV, Issue III
United States
- FDA Reorganizes ORA Staff
- Senators Urge the Administration to Certify Imports of Prescription Drugs from Canada
Europe
- EMA Green Lights New EudraVigilance System for Adverse Reactions
- EU Medical Device Regulation 2017/745 and In Vitro Diagnostic Regulation 2017/746
- Guidance for European MA Holders to Prepare for Brexit
- EMA Calls for Public Consultation on Clinical Trial Protocol
- New French Decree Clarifies the Scope of Biomedical Research
Publications of Interest
Jones Day publications should not be construed as legal advice on any specific facts or circumstances. The contents are intended for general information purposes only and may not be quoted or referred to in any other publication or proceeding without the prior written consent of the Firm, to be given or withheld at our discretion. To request reprint permission for any of our publications, please use our "Contact Us" form, which can be found on our web site at www.jonesday.com. The mailing of this publication is not intended to create, and receipt of it does not constitute, an attorney-client relationship. The views set forth herein are the personal views of the authors and do not necessarily reflect those of the Firm.